Skip to main content
. Author manuscript; available in PMC: 2013 Jul 3.
Published in final edited form as: Sci Am. 2009 Feb;300(2):44–51. doi: 10.1038/scientificamerican0209-44

Passive Tumor Targeting.

Passive Tumor Targeting

When the particles enter a patient’s bloodstream, they circulate freely but cannot penetrate most blood vessel walls. Tumor vessels are abnormally leaky, with large pores that allow nanoparticles to pass through and accumulate in the tumor tissue.